IRIS Accounts Production v25.4.0.155 14788437 Board of Directors 1.10.24 30.9.25 30.9.25 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147884372024-09-30147884372025-09-30147884372024-10-012025-09-30147884372023-04-09147884372023-04-102024-09-30147884372024-09-3014788437ns15:EnglandWales2024-10-012025-09-3014788437ns14:PoundSterling2024-10-012025-09-3014788437ns10:Director12024-10-012025-09-3014788437ns10:PrivateLimitedCompanyLtd2024-10-012025-09-3014788437ns10:SmallEntities2024-10-012025-09-3014788437ns10:AuditExempt-NoAccountantsReport2024-10-012025-09-3014788437ns10:SmallCompaniesRegimeForDirectorsReport2024-10-012025-09-3014788437ns10:SmallCompaniesRegimeForAccounts2024-10-012025-09-3014788437ns10:FullAccounts2024-10-012025-09-3014788437ns10:OrdinaryShareClass12024-10-012025-09-3014788437ns10:OrdinaryShareClass22024-10-012025-09-3014788437ns10:Director22024-10-012025-09-3014788437ns10:RegisteredOffice2024-10-012025-09-3014788437ns5:CurrentFinancialInstruments2025-09-3014788437ns5:CurrentFinancialInstruments2024-09-3014788437ns5:ShareCapital2025-09-3014788437ns5:ShareCapital2024-09-3014788437ns5:RetainedEarningsAccumulatedLosses2025-09-3014788437ns5:RetainedEarningsAccumulatedLosses2024-09-3014788437ns5:PlantMachinery2024-10-012025-09-3014788437ns5:FurnitureFittings2024-10-012025-09-3014788437ns5:ComputerEquipment2024-10-012025-09-3014788437ns5:PlantMachinery2024-09-3014788437ns5:FurnitureFittings2024-09-3014788437ns5:ComputerEquipment2024-09-3014788437ns5:PlantMachinery2025-09-3014788437ns5:FurnitureFittings2025-09-3014788437ns5:ComputerEquipment2025-09-3014788437ns5:PlantMachinery2024-09-3014788437ns5:FurnitureFittings2024-09-3014788437ns5:ComputerEquipment2024-09-3014788437ns10:OrdinaryShareClass12025-09-3014788437ns10:OrdinaryShareClass22025-09-3014788437ns5:RetainedEarningsAccumulatedLosses2024-09-3014788437ns5:RetainedEarningsAccumulatedLosses2024-10-012025-09-30
REGISTERED NUMBER: 14788437 (England and Wales)







Unaudited Financial Statements

for the Year Ended 30th September 2025

for

Raw Health Limited

Raw Health Limited (Registered number: 14788437)






Contents of the Financial Statements
for the Year Ended 30th September 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Raw Health Limited

Company Information
for the Year Ended 30th September 2025







DIRECTORS: Mr A A Williams
Mrs R Williams





REGISTERED OFFICE: Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY





REGISTERED NUMBER: 14788437 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY

Raw Health Limited (Registered number: 14788437)

Balance Sheet
30th September 2025

30.9.25 30.9.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 43,747 51,567

CURRENT ASSETS
Debtors 5 283 -
Cash at bank 30,452 3,079
30,735 3,079
CREDITORS
Amounts falling due within one year 6 110,606 99,310
NET CURRENT LIABILITIES (79,871 ) (96,231 )
TOTAL ASSETS LESS CURRENT LIABILITIES (36,124 ) (44,664 )

PROVISIONS FOR LIABILITIES 8,312 9,798
NET LIABILITIES (44,436 ) (54,462 )

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 (44,536 ) (54,562 )
SHAREHOLDERS' FUNDS (44,436 ) (54,462 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28th November 2025 and were signed on its behalf by:





Mr A A Williams - Director


Raw Health Limited (Registered number: 14788437)

Notes to the Financial Statements
for the Year Ended 30th September 2025

1. STATUTORY INFORMATION

Raw Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33.33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The company is reliant on the support of its director and shareholders and having made appropriate enquiries, the director has considered the future cashflow of the company and is not aware of any reason why the company will not be able to meet its liabilities as they fall due for the foreseeable future. As a result the director has continued to adopt the going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - NIL ) .

Raw Health Limited (Registered number: 14788437)

Notes to the Financial Statements - continued
for the Year Ended 30th September 2025

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1st October 2024 61,069 4,662 1,638 67,369
Additions - 6,588 120 6,708
At 30th September 2025 61,069 11,250 1,758 74,077
DEPRECIATION
At 1st October 2024 15,170 269 363 15,802
Charge for year 11,474 2,601 453 14,528
At 30th September 2025 26,644 2,870 816 30,330
NET BOOK VALUE
At 30th September 2025 34,425 8,380 942 43,747
At 30th September 2024 45,899 4,393 1,275 51,567

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Prepayments 283 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Trade creditors 691 -
Directors' current accounts 108,025 97,511
Accrued expenses 1,890 1,799
110,606 99,310

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.25 30.9.24
value: £    £   
50 A Ordinary £1 50 50
50 B Ordinary £1 50 50
100 100

8. RESERVES
Retained
earnings
£   

At 1st October 2024 (54,562 )
Profit for the year 10,026
At 30th September 2025 (44,536 )